Nanofilament-Directed Immunotherapy Ignites Robust Antitumor Vaccine Responses & Overcomes Neoantigen Prediction Bottlenecks
Time: 2:00 pm
day: Conference Day One
Details:
• Bioengineered nanofilaments bypass the need to map individual neoantigens by directly converting cancer cells into targets for the immune system
• Nanofilament biologic activities orchestrate the immune response – from tumor antigen capture to T-cell activation
• Nanofilament-Directed Immunotherapy offers an off-the-shelf solution to ignite a robust antitumor vaccine response against the patient’s complete tumor antigen repertoire
